However, some data suggest that bortezomib can also be linked to downregulation of IkBα expression, and therefore paradoxically promote NFkB activation in myeloma cells lines and primary tumors cells, suggesting a more complex mechanism of action that may explain the unsuccessful results obtained in HL. Here, NFKB1 is linked to Hodgkins lymphoma.